Hedge Funds Are Crazy About Revolution Medicines, Inc. (RVMD)

A whopping number of 13F filings filed with U.S. Securities and Exchange Commission has been processed by Insider Monkey so that individual investors can look at the overall hedge fund sentiment towards the stocks included in their watchlists. These freshly-submitted public filings disclose money managers’ equity positions as of the end of the three-month period that ended June 30th, so let’s proceed with the discussion of the hedge fund sentiment on Revolution Medicines, Inc. (NASDAQ:RVMD).

Is Revolution Medicines, Inc. (NASDAQ:RVMD) the right investment to pursue these days? Investors who are in the know were taking an optimistic view. The number of bullish hedge fund positions advanced by 3 recently. Revolution Medicines, Inc. (NASDAQ:RVMD) was in 29 hedge funds’ portfolios at the end of June. The all time high for this statistic was previously 26. This means the bullish number of hedge fund positions in this stock currently sits at its all time high. Our calculations also showed that RVMD isn’t among the 30 most popular stocks among hedge funds (click for Q2 rankings).

To most investors, hedge funds are assumed to be unimportant, outdated investment tools of yesteryear. While there are more than 8000 funds with their doors open today, Our experts look at the crème de la crème of this group, about 850 funds. These money managers command the lion’s share of all hedge funds’ total capital, and by shadowing their matchless picks, Insider Monkey has unearthed many investment strategies that have historically outstripped the broader indices. Insider Monkey’s flagship short hedge fund strategy outstripped the S&P 500 short ETFs by around 20 percentage points a year since its inception in March 2017. Also, our monthly newsletter’s portfolio of long stock picks returned 185.4% since March 2017 (through August 2021) and beat the S&P 500 Index by more than 79 percentage points. You can download a sample issue of this newsletter on our website.

James Flynn Deerfield Management

James E. Flynn of Deerfield Management

At Insider Monkey, we scour multiple sources to uncover the next great investment idea. For example, lithium mining is one of the fastest growing industries right now, so we are checking out stock pitches like this emerging lithium stock. We go through lists like the 10 best EV stocks to pick the next Tesla that will deliver a 10x return. Even though we recommend positions in only a tiny fraction of the companies we analyze, we check out as many stocks as we can. We read hedge fund investor letters and listen to stock pitches at hedge fund conferences. You can subscribe to our free daily newsletter on our homepage. Now let’s take a gander at the latest hedge fund action surrounding Revolution Medicines, Inc. (NASDAQ:RVMD).

Do Hedge Funds Think RVMD Is A Good Stock To Buy Now?

At the end of June, a total of 29 of the hedge funds tracked by Insider Monkey were bullish on this stock, a change of 12% from the previous quarter. On the other hand, there were a total of 13 hedge funds with a bullish position in RVMD a year ago. So, let’s check out which hedge funds were among the top holders of the stock and which hedge funds were making big moves.

More specifically, Cormorant Asset Management was the largest shareholder of Revolution Medicines, Inc. (NASDAQ:RVMD), with a stake worth $106 million reported as of the end of June. Trailing Cormorant Asset Management was Farallon Capital, which amassed a stake valued at $79.4 million. Biotechnology Value Fund / BVF Inc, Casdin Capital, and Deerfield Management were also very fond of the stock, becoming one of the largest hedge fund holders of the company. In terms of the portfolio weights assigned to each position Cormorant Asset Management allocated the biggest weight to Revolution Medicines, Inc. (NASDAQ:RVMD), around 3.6% of its 13F portfolio. Biotechnology Value Fund / BVF Inc is also relatively very bullish on the stock, earmarking 2.96 percent of its 13F equity portfolio to RVMD.

Consequently, specific money managers were leading the bulls’ herd. Point72 Asset Management, managed by Steve Cohen, established the biggest position in Revolution Medicines, Inc. (NASDAQ:RVMD). Point72 Asset Management had $6.1 million invested in the company at the end of the quarter. Paul Tudor Jones’s Tudor Investment Corp also made a $2.4 million investment in the stock during the quarter. The other funds with new positions in the stock are Christiana Goh Bardon’s Burrage Capital Management, Paul Marshall and Ian Wace’s Marshall Wace LLP, and Mika Toikka’s AlphaCrest Capital Management.

Let’s now review hedge fund activity in other stocks similar to Revolution Medicines, Inc. (NASDAQ:RVMD). We will take a look at Trinseo S.A. (NYSE:TSE), Plains GP Holdings LP (NASDAQ:PAGP), Industrias Bachoco, S.A.B. de C.V. (NYSE:IBA), XPEL Inc. (NASDAQ:XPEL), Washington Federal Inc. (NASDAQ:WAFD), First Financial Bancorp (NASDAQ:FFBC), and Compañía de Minas Buenaventura S.A.A. (NYSE:BVN). This group of stocks’ market valuations are closest to RVMD’s market valuation.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
TSE 17 41352 0
PAGP 15 77499 0
IBA 2 34534 0
XPEL 24 154749 10
WAFD 16 134874 -2
FFBC 7 10863 -4
BVN 8 40256 1
Average 12.7 70590 0.7

View table here if you experience formatting issues.

As you can see these stocks had an average of 12.7 hedge funds with bullish positions and the average amount invested in these stocks was $71 million. That figure was $485 million in RVMD’s case. XPEL Inc. (NASDAQ:XPEL) is the most popular stock in this table. On the other hand Industrias Bachoco, S.A.B. de C.V. (NYSE:IBA) is the least popular one with only 2 bullish hedge fund positions. Compared to these stocks Revolution Medicines, Inc. (NASDAQ:RVMD) is more popular among hedge funds. Our overall hedge fund sentiment score for RVMD is 88. Stocks with higher number of hedge fund positions relative to other stocks as well as relative to their historical range receive a higher sentiment score. Our calculations showed that top 5 most popular stocks among hedge funds returned 95.8% in 2019 and 2020, and outperformed the S&P 500 ETF (SPY) by 40 percentage points. These stocks gained 24.9% in 2021 through October 15th and still beat the market by 4.5 percentage points. Unfortunately RVMD wasn’t nearly as popular as these 5 stocks and hedge funds that were betting on RVMD were disappointed as the stock returned -15.1% since the end of the second quarter (through 10/15) and underperformed the market. If you are interested in investing in large cap stocks with huge upside potential, you should check out the top 5 most popular stocks among hedge funds as most of these stocks already outperformed the market since 2019.

Follow Revolution Medicines Inc. (NASDAQ:RVMD)

Suggested Articles:

Disclosure: None. This article was originally published at Insider Monkey.